Related Experiment Video

Updated: Jun 11, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Advances in the understanding of MYH9 disorders

Shinji Kunishima1, Hidehiko Saito

  • 1Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan. kunishis@nnh.hosp.go.jp

Current Opinion in Hematology
|July 6, 2010
PubMed

Insights

MYH9 disorders, caused by mutations in the nonmuscle myosin heavy chain IIA gene, lead to severe macrothrombocytopenia and increase the risk of kidney and hearing issues. Genetic diagnosis is crucial for prognosis and management.

Area of Science:

  • Genetics
  • Hematology
  • Nephrology

Background:

  • MYH9 disorders are inherited conditions characterized by abnormal platelet size and number, often associated with leukocyte inclusions.
  • These disorders stem from mutations in the MYH9 gene, which encodes nonmuscle myosin heavy chain IIA.

Purpose of the Study:

  • To review recent advancements in the genetic diagnosis of MYH9 disorders.
  • To summarize current understanding of the pathogenetic mechanisms underlying MYH9 mutations.
  • To explore the development of nonhematological complications associated with these disorders.

Main Methods:

  • Genotype-phenotype correlation analysis in a patient cohort.
  • In-vitro studies using cultured megakaryocytes.
  • Renal histopathological and immunochemical examinations.

Main Results:

  • MYH9 mutations in the motor head domain correlate with severe macrothrombocytopenia, glomerulonephritis, and deafness, with Arg702 mutations showing the most severe phenotype.
  • Loss of myosin IIA function due to MYH9 mutations enhances proplatelet formation, leading to macrothrombocytopenia.
  • Glomerulonephritis in MYH9 disorders is linked to podocyte dysfunction resulting from myosin IIA structural defects and altered gene expression.

Conclusions:

  • MYH9 disorders are systemic conditions with significant nonhematological manifestations, including kidney, inner ear, and lens abnormalities.
  • Accurate genetic diagnosis is essential for predicting nonhematological complications and guiding patient management, potentially including prophylactic treatments.
Abstract

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

In Vivo Modeling of the Morbid Human Genome using Danio rerio12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...